GRAIL, Inc. Sees Stock Surge as FDA Panel Reviews Galleri Cancer Test

In a pivotal moment for GRAIL, Inc. (NASDAQ: GRAL), the biotechnology company’s stock saw a dramatic surge as investors anticipate a crucial FDA panel review of its Galleri cancer test. As of the latest trading session, GRAIL’s stock has skyrocketed by 33.68%, with shares trading at $107.97, up from a previous close of $80.77. This […]

US Sanctions Prompt Airlines to Cancel Flights to Iran

US sanctions have led to the cancellation of flights to Iran by major airlines, demonstrating the impact of geopolitical tensions on global air travel. Rising fuel prices are also causing airlines to adjust their routes.